Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Hedner

Showing results (21-30 of 126) with videos related to

Pageof 13
Sort By:
Blood Pressure|November 5, 2003
Recent hypertension guidelines: JNC-7 and 2003 ESH/ESCAnders Himmelmann, Sverre E Kjeldsen, Thomas Hedner
Blood Pressure. Supplement|June 15, 2007
There is a need for more aggressive implementation of combination strategies to control hypertensive riskThomas Hedner, Krzysztof Narkiewicz, Sverre E Kjeldsen
Blood Pressure|April 16, 2004
Prevention of cardiovascular disease in uncomplicated, mild hypertension--need for prospective data from intervention trialsSverre E Kieldsen, Thomas Hedner, Anders Himmelmann
Blood Pressure|November 1, 2005
Hypertension and coronary artery disease: mechanistic insights and therapeutic challengesKrzysztof Narkiewicz, Sverre E Kjeldsen, Thomas Hedner
Blood Pressure|October 25, 2006
Medical decision making in hypertensionThomas Hedner, Krzysztof Narkiewicz, Sverre E Kjeldsen
Blood Pressure|July 24, 2003
In light of ALLHAT and ASCOT: are there benefits of statins as add-on treatment in hypertensives?Sverre E Kjeldsen, Thomas Hedner, Anders Himmelman
Blood Pressure|November 1, 2005
ASCOT - more than a horse race!Sverre E Kjeldsen, Krzysztof Narkiewicz, Thomas Hedner
Blood Pressure|July 23, 2005
Health economy of the metabolic syndrome pandemicThomas Hedner, Sverre E Kjeldsen, Krzysztof Narkiewicz
Blood Pressure|July 20, 2012
State of global health--hypertension burden and controlThomas Hedner, Sverre E Kjeldsen, Krzysztof Narkiewicz
Blood Pressure|May 11, 2016
HOPE-3, SPRINT, VALUE and a meta-analysis of trials in patients with diabetes support treatment of hypertension to a target below 140 mmHgSverre E Kjeldsen, Thomas Hedner, Krzysztof Narkiewicz
Pageof 13

Showing results (21-30 of 126) with videos related to

Sort By:
Pageof 13
Blood Pressure|November 5, 2003
Recent hypertension guidelines: JNC-7 and 2003 ESH/ESCAnders Himmelmann, Sverre E Kjeldsen, Thomas Hedner
Blood Pressure. Supplement|June 15, 2007
There is a need for more aggressive implementation of combination strategies to control hypertensive riskThomas Hedner, Krzysztof Narkiewicz, Sverre E Kjeldsen
Blood Pressure|April 16, 2004
Prevention of cardiovascular disease in uncomplicated, mild hypertension--need for prospective data from intervention trialsSverre E Kieldsen, Thomas Hedner, Anders Himmelmann
Blood Pressure|November 1, 2005
Hypertension and coronary artery disease: mechanistic insights and therapeutic challengesKrzysztof Narkiewicz, Sverre E Kjeldsen, Thomas Hedner
Blood Pressure|October 25, 2006
Medical decision making in hypertensionThomas Hedner, Krzysztof Narkiewicz, Sverre E Kjeldsen
Blood Pressure|July 24, 2003
In light of ALLHAT and ASCOT: are there benefits of statins as add-on treatment in hypertensives?Sverre E Kjeldsen, Thomas Hedner, Anders Himmelman
Blood Pressure|November 1, 2005
ASCOT - more than a horse race!Sverre E Kjeldsen, Krzysztof Narkiewicz, Thomas Hedner
Blood Pressure|July 23, 2005
Health economy of the metabolic syndrome pandemicThomas Hedner, Sverre E Kjeldsen, Krzysztof Narkiewicz
Blood Pressure|July 20, 2012
State of global health--hypertension burden and controlThomas Hedner, Sverre E Kjeldsen, Krzysztof Narkiewicz
Blood Pressure|May 11, 2016
HOPE-3, SPRINT, VALUE and a meta-analysis of trials in patients with diabetes support treatment of hypertension to a target below 140 mmHgSverre E Kjeldsen, Thomas Hedner, Krzysztof Narkiewicz
Pageof 13